$INV

Innventure (INV) Q2 2026 Earnings Call Transcript

Innventure (INV) reported Q2 2026 revenue of $1M, up from $0.5M YoY, driven by Accelsius. Net loss widened to $34.9M vs. $27.8M QoQ. CEO Bill Haskell to retire; Bill Grieco to succeed. Accelsius faces adoption delays due to infrastructure constraints, shifting focus to hyperscalers. Cash position at $46.5M, down from $60.4M. Management withdrew 2028 cash flow target.

Original reporting
Published Aug 20, 2026, 11:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 12:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Innventure (INV) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$INVBearishMed
01

Why it matters

The earnings miss and guidance withdrawal increase short‑term risk, but the new CEO and fresh funding could improve long‑term prospects.

02

Market read

The earnings release provides fresh material for traders; the stock may see heightened volatility as investors digest the loss widening and leadership transition.

03

What to watch

Potential upside from upcoming Accelsius Series B funding led by Johnson Controls and strategic partnerships with hyperscalers.

Relevance 7/10Novelty 7/10Timing: Q2 2026 earnings released Aug 13 2026

Background

Innventure (INV) is a micro‑cap provider of two‑phase liquid‑cooling solutions for AI data centers. The Q2 2026 call disclosed financial results and a leadership change.

Company-level read

Ticker impact

$INVBearishHigh confidence
Context

Innventure reported Q2 2026 results with revenue of $1M, net loss of $34.9M and withdrew its 2028 cash‑flow guidance.

Expected impact

Potential short‑term downside as investors reassess cash‑burn and leadership transition.

Evidence & confidence

The disclosed loss widening, cash depletion and suspended guidance are fresh, material facts that directly affect valuation.

Market effects

Highlights challenges in the two‑phase liquid‑cooling market and may dampen enthusiasm for related AI‑infrastructure stocks.

Limited to U.S. micro‑cap investors; no broader regional effect.

Minimal global impact beyond niche cooling technology niche.

Counterpoint

If the leadership transition accelerates product commercialization, the stock could rebound despite short‑term cash concerns.

Key entities

  • Bill Haskell

    Outgoing CEO retiring Oct 1 2026.

  • Bill Grieco

    Incoming CEO, former CTO of Innventure.

  • Johnson Controls

    Lead investor in Accelsius Series B funding.

Related articles

$INVLow

INV Court Alert: Innventure Securities Fraud Class Action Deadline is Approaching on October 27 for Investors that Suffered Losses

Innventure Inc. (INV) faces a securities fraud class action lawsuit over alleged misrepresentations about Accelsius' DarkNX data center deal. The stock dropped 55% in August 2026 after Innventure suspended revenue targets, following a May 2026 report questioning the deal's validity. Investors have until October 27, 2026, to join the lawsuit.

$INVMed

Innventure, Inc. (INV): Results of Operations and Financial Condition

Innventure, Inc. (INV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Innventure Reports Second Quarter 2026 Results Accelsius focused on execution against foundational milestones to strengthen path to scaled two-phase adoption ORLANDO, Fla., August 13, 2026 (GLOBAL NEWSWIRE) – Innventure, Inc. (NASDAQ: INV) (“Innventure”), an industri

$INVMed

Placing and Offer for Subscription

The Board of The Investment Company plc (LSE: INV) published a circular to shareholders on 4 June 2026 outlining proposals for the company’s future. Plans include appointing Dowgate Wealth Limited as portfolio manager, adopting a new scarcity/resilience-focused investment policy, raising funds via a placing and offer for subscription, and providing a 100% exit option for qualifying shareholders not wishing to stay. Proposals require shareholder approval.

$INVMedAI 9/10

Innventure (INV) Q4 2025 Earnings Transcript

Innventure (INV) reported 2025 revenue of $2.1m vs. $1.2m in 2024, driven by Accelsius and AeroFlexx. Accelsius delivered $1.6m revenue (vs. $0.3m) and secured $50m+ in new Q1 bookings; Accelsius Series B closed at a ~$665m post-money valuation. Management expects Accelsius to be cash-flow positive by year-end. Cash rose to $65.4m; adjusted EBITDA loss was $78.8m.

$NVOHighAI 8/10

Novo Nordisk shares fall by up to 7% in Denmark — CNBC

Novo Nordisk shares dropped 7% in early trading on September 21, 2026, after the company announced new growth targets for its obesity treatment drugs. The firm aims to launch over five potential multi-blockbuster drugs by 2030 and expects sales of over 150 billion Danish kroner ($23 billion) by 2035. Novo Nordisk also anticipates matching industry revenue growth rates from 2026 to 2030.